Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Catherine Bollard, MD, MBChB

Director, Center for Cancer and Immunology


Catherine Bollard, M.B.Ch.B, M.D., is the Director of the Center for Cancer and Immunology Research at the Children’s Research Institute, Director of the Program for Cell Enhancement and Technologies for Immunotherapy and a member of the Division of the Blood and Marrow Transplantation. In addition, she is Professor of Pediatrics and Microbiology, Immunology and Tropical Medicine at the George Washington University and is the ACD for Translational Research and Innovation within the George Washington Cancer Center. In these roles, Dr. Bollard leads clinical and research efforts to fight cancer and other inflammatory diseases by strengthening the immune system using adoptive cell therapy. As the immediate past president of the International Society of Cellular Therapy, she is a distinguished hematologist, immunologist and immunotherapist, working to develop cell and gene therapies for patients with cancer and underlying immune deficiencies.

Additionally, Dr. Bollard is interested in stem cell and cord blood transplantation and improving outcomes by decreasing infectious complications and preventing relapse. She also has a specific interest in targeting viral infections in the immune suppression population, including individuals living with human immunodeficiency virus. Dr. Bollard is a member of the American Society for Clinical Investigation and is on the Board of Directors of the Foundation for the Accreditation of Cellular Therapy and Chairs the Non-Hodgkin Lymphoma committee of the Children’s Oncology Group. She is an associate editor for the journals Blood and Cytotherapy. Dr. Bollard is a member of the National Cancer Institute Clinical Oncology Study Section and the Cellular, Tissues and Gene Therapies Advisory Committee for the Food and Drug Administration.

As a national and international leader in the immunology and immunotherapy space, Dr. Bollard’s work expands our understanding of cancer, immune deficiencies and viral infections in pediatric and adult patients. She joined Children’s National from the Baylor College of Medicine where she was a tenured professor in the Department of Pediatrics. Prior to that, she served as a Postdoctoral Fellow at Texas Children’s Hospital. She received a medical degree from Otago University Medical School in New Zealand.

Education & Training

Education & Training

  • MD, 2005
    University of Otago
  • Fellowship Program, Peds Bone Marrow Transplant, 2001
    Texas Children's Hospital
  • Fellowship Program, Pediatric Hematology/Oncology, 2000
    Auckland University Hospital
  • Residency Program, Pediatric Hematology/Oncology, 1994
    Saint Bartholomew's Hospital
  • Residency Program, General Medicine, 1993
    Auckland University Hospital
  • MBCHB, 1991
    University of Otago
Patient Stories

Patient Stories: Catherine Bollard

Molly dancing

Molly's Story

Saved by a bone marrow donation from her brother, Davis, and strengthened by a personalized T-cell therapy post transplant, Molly’s life is back on track and she’s dancing again.



NIAID and Children's National partner to advance pediatric clinical research

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and Children’s National Health System, a pediatric academic medical center in Washington, have launched a clinical research partnership devoted to treating and preventing allergic, immunologic and infectious diseases in children. An inaugural symposium will take place at Children’s National on Sept. 17, 2018, to highlight the partnership and discuss current and future directions for its research activities.

Children’s National becomes first pediatric medical institution in the United States to receive combined FACT accreditation related to cellular immunotherapy

Today Children’s National Health System became the first pediatric medical institution in the United States to receive accreditations for both immune effector cells and more than minimal manipulation from the Foundation for the Accreditation of Cellular Therapy (FACT). Considered the threshold for excellence in cellular therapy, FACT establishes standards for high-quality medical and laboratory practice in the field.   

Invest in future cures for some of life's most devastating diseases

See other ways to give
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you. Make it happen

Tyson and Tyler's Story

conjoined twins

Before they had even entered the world, Children's National doctors had hatched a plan to safely deliver and then separate conjoined twins Tyson and Tyler.

Read More of Tyson and Tyler's Story